Publications by authors named "Jorunn E Eyfjord"

34Publications

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article and Find Full Text PDF
February 2019

Telomere Length Is Predictive of Breast Cancer Risk in Mutation Carriers.

Cancer Epidemiol Biomarkers Prev 2017 08 24;26(8):1248-1254. Epub 2017 Feb 24.

Cancer Research Laboratory, Biomedical Center, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article and Find Full Text PDF
August 2017

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article and Find Full Text PDF
June 2016

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers.

J Pathol Clin Res 2015 Jan 7;1(1):33-40. Epub 2014 Nov 7.

Cancer Research Laboratory, Biomedical Center, Faculty of Medicine, School of Health Sciences, University of Iceland Reykjavik Iceland.

View Article and Find Full Text PDF
January 2015

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition.

Cancer Res 2014 Oct 8;74(19):5608-19. Epub 2014 Aug 8.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat; Barcelona, Spain. Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

View Article and Find Full Text PDF
October 2014

Linkage of DNA methylation quantitative trait loci to human cancer risk.

Cell Rep 2014 Apr 3;7(2):331-338. Epub 2014 Apr 3.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, 08036 Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Catalonia, Spain. Electronic address:

View Article and Find Full Text PDF
April 2014

DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker.

Carcinogenesis 2013 Jan 10;34(1):102-8. Epub 2012 Oct 10.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia 08907, Spain.

View Article and Find Full Text PDF
January 2013

Tetraploidy in BRCA2 breast tumours.

Eur J Cancer 2012 Feb 29;48(3):305-10. Epub 2011 Nov 29.

Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article and Find Full Text PDF
February 2012

Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines.

Mutat Res 2012 Jan 12;729(1-2):90-9. Epub 2011 Oct 12.

Cancer Research Laboratory, BioMedical Centre, University of Iceland, Reykjavik, Iceland.

View Article and Find Full Text PDF
January 2012

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression.

Breast Cancer Res 2011 Sep 29;13(5):R95. Epub 2011 Sep 29.

Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik, Iceland.

View Article and Find Full Text PDF
September 2011

Cytogenetic polyclonality of breast carcinomas: association with clinico-pathological characteristics and outcome.

Genes Chromosomes Cancer 2011 Nov 24;50(11):930-9. Epub 2011 Aug 24.

Chromosome Laboratory, Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavík, Iceland.

View Article and Find Full Text PDF
November 2011

Centriole movements in mammalian epithelial cells during cytokinesis.

BMC Cell Biol 2010 May 21;11:34. Epub 2010 May 21.

Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article and Find Full Text PDF
May 2010

MYC amplification and TERT expression in breast tumor progression.

Cancer Genet Cytogenet 2007 Jul;176(2):93-9

Department of Medicine, University of Iceland, Vatnsmýrarvegi 16, 101 Reykjavik, Iceland.

View Article and Find Full Text PDF
July 2007

Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.

Cancer Lett 2007 Jun 17;250(2):206-12. Epub 2006 Nov 17.

Molecular and Cell Biology Research Laboratory, Icelandic Cancer Society, Skogarhlid 8, 105 Reykjavik, Iceland.

View Article and Find Full Text PDF
June 2007

Aurora-A amplification associated with BRCA2 mutation in breast tumours.

Cancer Lett 2007 Apr 24;248(1):96-102. Epub 2006 Jul 24.

Icelandic Cancer Society, Skogarhlid 8, 105 Reykjavik, Iceland; University of Iceland, Department of Medicine, Vatnsmyrarvegi 16, 101 Reykjavik, Iceland.

View Article and Find Full Text PDF
April 2007

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

Breast Cancer Res 2006 ;8(4):R38

The Icelandic Cancer Society, Molecular and Cell Biology Research Laboratory, Reykjavik, Iceland.

View Article and Find Full Text PDF
January 2007

The Icelandic founder mutation BRCA2 999del5: analysis of expression.

Breast Cancer Res 2004 7;6(4):R284-90. Epub 2004 Apr 7.

Molecular and Cell Biology Laboratory, The Icelandic Cancer Society, Reykjavik, Iceland.

View Article and Find Full Text PDF
November 2004

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Oncogene 2003 Jan;22(3):445-50

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article and Find Full Text PDF
January 2003

Breast cancer risk factors and age at diagnosis: an Icelandic cohort study.

Int J Cancer 2002 Apr;98(4):604-8

Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.

View Article and Find Full Text PDF
April 2002